Oceanside, CA - March 18, 2026 - PRESSADVANTAGE - Moment of Clarity has released a new educational resource examining ...

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

Swedish people with depression and anxiety who took Novo Nordisk A/S’s blockbuster shots Ozempic and Wegovy were less likely ...

Amanda Miller was 30 and pregnant with her second child in Hershey, Pennsylvania, when she developed depression. After she gave birth, her depression worsened. It was joined by a slew of unexplained ...

Recent research has opened the debate on whether chemical imbalances cause depression, anxiety, and other conditions ...

Depression or ADHD? Neatly delineated diagnoses fail to do justice to the infinitely complex reality that they refer to, ...

Depression and suicidal ideation are stubbornly high among college students despite increased efforts by universities to combat the long-growing problem. While nearly all four-year institutions and ...

There’s ‘no evidence’ marijuana works to treat most mental health disorders, largest review of its kind finds - More than 52 ...

A new analysis represents the largest effort yet to systematically parse all the data from high-quality clinical trials on cannabis and mental health. The evidence is lacking.

The study findings may spark treatment innovations for depression and anxiety.